Scott T. Rottinghaus
CIK 1942407 · Chief Medical Officer · last filed 2026-02-13
Scott T. Rottinghaus is a Chief Medical Officer who has filed 14 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for ENTA, was dated Feb 13, 2026. Across all open-market trades the lifetime net is −$214.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $300.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$300.5K
1
14
-$214.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTA | Chief Medical Officer | 25,254 | $11.90 | $300.5K | -$214.2K | 14 | 2026-02-13 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-13 | ENTA | Mixed | +3,462 | -$48.6K | EDGAR |
| 2025-12-05 | ENTA | Sell (S) | −798 | -$11.4K | EDGAR |
| 2025-11-26 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2025-08-08 | ENTA | Tax (F) | −2,217 | -$15.5K | EDGAR |
| 2025-02-14 | ENTA | Mixed | +6,889 | -$16.0K | EDGAR |
| 2024-12-10 | ENTA | Sell (S) | −866 | -$7.0K | EDGAR |
| 2024-11-27 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2024-08-09 | ENTA | Tax (F) | −2,933 | -$43.9K | EDGAR |
| 2024-07-15 | ENTA | Mixed | −6,570 | -$142.4K | EDGAR |
| 2024-02-14 | ENTA | Mixed | +1,821 | -$9.4K | EDGAR |